Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Bjerring Olesen

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Thrombosis and Haemostasis|March 7, 2015
Stroke risk in atrial fibrillation: Do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?Jonas Bjerring Olesen, Christian Torp-Pedersen
Journal of the American College of Cardiology|March 21, 2020
When Oral Anticoagulation Becomes DifficultJonas Bjerring Olesen, Anders Nissen Bonde
Journal of the American College of Cardiology|March 5, 2020
Reply: Anticoagulant Therapy and Hip Fracture Risk: A Possible Involvement of Physical ActivityCasper Binding, Jonas Bjerring Olesen, Anders Nissen Bonde
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 12, 2014
The atrial fibrillation epidemic: a validated diagnosis, or not?Jonas Bjerring Olesen, Gregory Y H Lip, Laurent Fauchier
Ugeskrift for Laeger|November 12, 2024
Bo Løfgren, Jonas Bjerring Olesen, Ulla Davidsen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 20, 2011
An epidemic of atrial fibrillation?Jonas Bjerring Olesen, Gregory Y H Lip, Deirdre A Lane
Clinical Cardiology|January 17, 2012
Atrial fibrillation and vascular disease--a bad combinationJonas Bjerring Olesen, Gunnar Hilmar Gislason, Christian Torp-Pedersen, et al.
Thrombosis and Haemostasis|April 5, 2012
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort studyJonas Bjerring Olesen, Christian Torp-Pedersen, Morten Lock Hansen, et al.
BMJ Open|January 29, 2013
Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort studyChristine Benn Christiansen, Jonas Bjerring Olesen, Gunnar Gislason, et al.
Chest|June 18, 2011
Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation ProjectJonas Bjerring Olesen, Laurent Fauchier, Deirdre A Lane, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Thrombosis and Haemostasis|March 7, 2015
Stroke risk in atrial fibrillation: Do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?Jonas Bjerring Olesen, Christian Torp-Pedersen
Journal of the American College of Cardiology|March 21, 2020
When Oral Anticoagulation Becomes DifficultJonas Bjerring Olesen, Anders Nissen Bonde
Journal of the American College of Cardiology|March 5, 2020
Reply: Anticoagulant Therapy and Hip Fracture Risk: A Possible Involvement of Physical ActivityCasper Binding, Jonas Bjerring Olesen, Anders Nissen Bonde
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 12, 2014
The atrial fibrillation epidemic: a validated diagnosis, or not?Jonas Bjerring Olesen, Gregory Y H Lip, Laurent Fauchier
Ugeskrift for Laeger|November 12, 2024
Bo Løfgren, Jonas Bjerring Olesen, Ulla Davidsen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 20, 2011
An epidemic of atrial fibrillation?Jonas Bjerring Olesen, Gregory Y H Lip, Deirdre A Lane
Clinical Cardiology|January 17, 2012
Atrial fibrillation and vascular disease--a bad combinationJonas Bjerring Olesen, Gunnar Hilmar Gislason, Christian Torp-Pedersen, et al.
Thrombosis and Haemostasis|April 5, 2012
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort studyJonas Bjerring Olesen, Christian Torp-Pedersen, Morten Lock Hansen, et al.
BMJ Open|January 29, 2013
Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort studyChristine Benn Christiansen, Jonas Bjerring Olesen, Gunnar Gislason, et al.
Chest|June 18, 2011
Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation ProjectJonas Bjerring Olesen, Laurent Fauchier, Deirdre A Lane, et al.
Pageof 13